Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lymphoid-specific helicase (Lsh) is crucial for skin growth, change, and healing after injury.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

JMJD3 and NF-κB activate Notch1, which is essential for skin cell movement and wound healing.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

LncRNA RP11-818O24.3 may help treat hair loss by boosting hair follicle stem cell growth and differentiation.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.

IL-27 may help prevent hair loss in alopecia areata by promoting immunosuppressive T cells.

Lrig1 could be a marker for advanced sebaceous carcinoma.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

lncRNA2919 slows down rabbit hair growth by stopping cell growth and causing cell death.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

RIPK1 inhibitors might help prevent alopecia areata.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Activating TLR3 boosts autophagy gene expression in skin cells.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

lncRNAs are important for understanding and treating skin diseases.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Blocking interferon-gamma might help treat various autoimmune diseases.

Integrin-linked kinase is crucial for normal skin healing.

CXCR3+ T cells and B cells drive skin disease and hair loss in lupus, with potential targets identified for treatment.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.